Self-management support for insulin therapy in type 2 diabetes

被引:47
作者
Funnell, MM [1 ]
Kruger, DF [1 ]
Spencr, M [1 ]
机构
[1] Michigan Diabet Res & Training Ctr, Ann Arbor, MI 48109 USA
关键词
D O I
10.1177/014572170403000220
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE The purpose of this article is to describe the self-management support that can be provided by diabetes educators for type 2 diabetes patients who are transitioning from therapy with oral hypoglycemic agents to insulin. METHODS The role of the diabetes educator in patient education and self-management support during all aspects of insulin therapy is discussed. Phases during which support may be especially important include the decision-making process, initiation, and maintenance. RESULTS Although some patients make the decision fairly easily, the introduction of insulin therapy is likely to raise many issues and questions for many type 2 diabetes patients. The more reluctant patients may experience psychological insulin resistance, a syndrome where insulin therapy is viewed as a threat or failure, which can affect health professionals as well. The diabetes educator can provide support and approaches to bel. p diminish this resistance and make the transition to insulin therapy easier and more effective for patients with type 2 diabetes. CONCLUSIONS Education and ongoing self-management support are needed for informed decision making and the initiation and maintenance Of insulin therapy. Therefore, diabetes educators have a critical role to play during both the decision-making process and the safe transition to insulin therapy.
引用
收藏
页码:274 / 280
页数:7
相关论文
共 24 条
[1]  
*AM ASS CLIN END, 2002, ENDOCR PRACT S1, V8, P41
[2]  
American Diabetes Association, 2004, DIABETES CARE, V27, pS1
[3]   Physiological insulin replacement in type 1 diabetes mellitus [J].
Bolli, GB .
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2001, 109 :S317-S332
[4]  
*DAWN STUD, 2002, PRACT DIAB INT, V19, pA22
[5]  
EDELMAN SV, 1995, DIABETES REV, V3, P308
[6]  
Fitzgerald JT, 2000, DIABETES, V49, pA445
[7]   Glimepiride combined with morning insulin glargine, bedtime neutral protamine Hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes -: A randomized, controlled trial [J].
Fritsche, A ;
Schweitzer, MA ;
Häring, HU .
ANNALS OF INTERNAL MEDICINE, 2003, 138 (12) :952-959
[8]   NIDDM patients' fears and hopes about insulin therapy - The basis of patient reluctance [J].
Hunt, LM ;
Valenzuela, MA ;
Pugh, JA .
DIABETES CARE, 1997, 20 (03) :292-298
[9]  
KORBEL G, 2003, PRACTICAL DIABETOL, V22, P36
[10]   When oral agents fail: practical barriers to starting insulin [J].
Korytkowski, M .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (Suppl 3) :S18-S24